HINGHAM, Mass. , Dec. 27, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ) closed its previously announced registered direct offering of 912,858 shares of its common stock at a purchase price of $10.50 per share for total gross proceeds of approximately $9.59 million , before
HINGHAM, Mass. , Dec. 26, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today announced that it has entered into definitive agreements with certain
Live Demonstration Planned for Monday, January 13, 2020 , in San Francisco Breakthrough technology features compact design, remote operation capabilities and an integrated “One & Done” tool to democratize endovascular procedures HINGHAM, Mass. , Dec. 23, 2019 (GLOBE NEWSWIRE) -- Microbot Medical
HINGHAM, Mass. , Nov. 25, 2019 (GLOBE NEWSWIRE) -- Further demonstrating its commitment to expand and protect its Intellectual Property (IP) portfolio, Microbot Medical Inc. (Nasdaq: MBOT) was issued a Notice of Allowance for patent application No. 15/936,878 by the U.S.
HINGHAM, Mass. , Oct. 30, 2019 (GLOBE NEWSWIRE) -- In an expansion of its significant global patent estate, Microbot Medical Inc. (Nasdaq: MBOT) announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.
Maintains Regulatory Pre-Submission Timeline of the Self-Cleaning Shunt (SCS TM ) HINGHAM, Mass. , Sept. 13, 2019 (GLOBE NEWSWIRE) -- Having successfully executed a number of significant milestones over the past twelve months, Microbot Medical Inc. (NASDAQ: MBOT) held its 2019 annual shareholders'
Positive Results Continue to Validate the Operational Effectiveness of the SCS™ HINGHAM, Mass. , Sept. 10, 2019 (GLOBE NEWSWIRE) -- Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational effectiveness of Microbot
HINGHAM, Mass. , Sept. 05, 2019 (GLOBE NEWSWIRE) -- At the upcoming Rodman & Renshaw Global Investment Conference , Harel Gadot , CEO, President and Chairman of Microbot Medical Inc. (Nasdaq: MBOT), will demonstrate a working prototype of the Company’s Self-Cleaning Shunt (SCS™). Mr.
HINGHAM, Mass. , July 24, 2019 (GLOBE NEWSWIRE) -- As it continues to expand and diversify its Intellectual Property (IP) portfolio, Microbot Medical (Nasdaq: MBOT) announced that it has received a Notice of Allowance from the Israel Intellectual Property Office for Patent Application No .
